Trial
News and Video Search Results
News coverage
-
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC
PR Newswire Asia
-
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
GlobeNewswire
0 shares
1 views
You might like
Trial media coverage
FDA commissioner Robert Califf: The risk of being dead is lower if you're vaccinated
Rumble
"I remind you the initial vaccine trial that led to the EUA did show a dramatic reduction in the rate of infection in the..
-
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
GlobeNewswire
-
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
GlobeNewswire
-
Primary school teacher admits killing boyfriend and burying body in garden mid-murder trial
Daily Record
-
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024
GlobeNewswire
Advertisement
More coverage
Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management
GlobeNewswire
Not for distribution to United States news wire services or for dissemination in the United StatesTORONTO and HOUSTON, April 26,..
-
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024
GlobeNewswire
-
Global Cell and Gene Therapies in Hemophilia A & B Analysis Report 2024: Market to Reach $2.2 Billion by 2029 - Major Players Are Expected To Intensify Competition
GlobeNewswire
-
Hospital applies to trial Martha's Rule
BBC Local News
-
Antibody-Drug Conjugates (ADC) Industry Overview 2024: Market to Exceed $40 Billion by 2029, Driven by Daiichi Sankyo's Enhertu, Roche's Kadcyla, Astellas Pharma, Pfizer's Padcev, & Gilead's Trodelvy
GlobeNewswire